Last news
Havas Health & You Appoints Internationally Recognized Creative Alex Okada as Chief Creative Officer of Havas Lynx Group

Havas Health & You Appoints Internationally Recognized Creative Alex Okada as Chief Creative Officer of Havas Lynx Group

...

HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial

HistoSonics Announces FDA Approval of its Pivotal IDE #HOPE4KIDNEY Trial

...

Wondershare Filmora Recognized as Category Leader by GetAPP

Wondershare Filmora Recognized as Category Leader by GetAPP

...

Global Times: How Xi leads China in all-out effort to tackle tech 'bottleneck' to secure development

Global Times: How Xi leads China in all-out effort to tackle tech 'bottleneck' to secure development

...

Ansell Applauded by Frost & Sullivan for Protecting Clinicians and Patients Using Latex-free Gloves, and Its Market-leading Position

Ansell Applauded by Frost & Sullivan for Protecting Clinicians and Patients Using Latex-free Gloves, and Its Market-leading Position

...

AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.

AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.

...

Randomized Controlled Trial Backs Clinical Efficacy of Lunit AI for Chest X-Ray

Randomized Controlled Trial Backs Clinical Efficacy of Lunit AI for Chest X-Ray

...

Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for Treatment of Relapsed/Refractory Multiple Myeloma

Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for Treatment of Relapsed/Refractory Multiple Myeloma

...

menu
menu